Skip to main content

FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall

The FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.